Panacea Life Sciences Holdings Inc 's ROA from the first quarter of 2024 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Panacea Life Sciences Holdings Inc 's ROA in the first quarter of 2024?
Panacea Life Sciences Holdings Inc recorded a cumulative net loss of $-8 million during 12 months ending in the first quarter of 2024, resulting in a negative return on assets (ROA) of -51.65%.

However, within the Consumer Non Cyclical sector 154 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2024 quarter, so far to 4237, from total ROA ranking in the fourth quarter of 2023 at 4895.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Total Assets Change	-10.22 %	-27.36 %	-5.35 %	-20.24 %	-13.21 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-8	-8	-8	-8	-8
Return On Assets (TTM)	-51.65 %	-52.49 %	-45.25 %	-47.88 %	-45.9 %
EXDI's Total Ranking	# 4237	# 4895	# 4312	# 4452	# 4553
Total Assets (TTM) in million	15	14	16	15	16
Seq. Total Assets Change	4.31 %	-10.42 %	6.56 %	-9.83 %	-15.6 %
Seq. Net Income Change	-	-	-	-	-

EXDI's 5 Years Annual ROA >> Back to EXDI Management Effectiveness >> Compare EXDI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 18
Sector	# 155
Overall	# 4164

Return On Assets Statistics
High	Average	Low
3.18 %	-623.26 %	-8930.82 %
(Dec 31 2021)		(Dec 31 2018)

Financial Statements
Panacea Life Sciences Holdings Inc 's Assets	$ 15 million	EXDI's Balance sheet
Panacea Life Sciences Holdings Inc 's Income	$ -1 million	Quarterly EXDI's Income Statement
EXDI's Income by Division		See EXDI's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	-18.14 %	-14.57 %	10006.1 %	-97.5 %	55778.26 %
Total Assets in million	14	17	20	0	8
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-8	-9	-5	-8	-9
Annual Return On Assets	-56.77 %	-53.01 %	-23.69 %	-3994.64 %	-114.58 %

EXDI's 5 Years Annual ROA >> Back to EXDI Management Effectiveness >> Compare EXDI ROA to its Competitors

More Return On Assets Ratios
EXDI's' Return on Assets at Yahoo Finance
Legal Cannabis Industry Return On Assets Trends and Statistics
Consumer Non Cyclical Sector Roa Statistics
Roa Trends for overall market
EXDI's Roa Ratio versus Legal Cannabis Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for EXDI's Competitors
Subscribers only: Roa for Panacea Life Sciences Holdings Inc 's Suppliers
Subscribers only: Return On Assets for EXDI's Customers

You may also want to know
EXDI's Roi	EXDI's Inventory Turnover Ratio	EXDI's Growth Rates	EXDI's Dividend Comparisons
	EXDI's Profitability Ratios	EXDI's Asset Turnover Ratio	EXDI's Dividend Growth
EXDI's Roe	EXDI's Valuation Ratios	EXDI's Financial Strength Ratios	EXDI's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2024, within Consumer Non Cyclical Sector

ROA

Date modified: 2026-09-08T15:11:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.